A multidisciplinary research team co-led by a prominent physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver…
Read More
Kerendia Recommended for Broader Heart Failure Treatment in England, Offering New Hope for Patients with Preserved Ejection Fraction
England’s National Health Service (NHS) is set to expand its treatment options for chronic heart failure (CHF) with the National…
Read More
Experimental Drug Shows Promise in Clearing Tau Tangles, Offering New Hope for Alzheimer’s Patients
LONDON – An experimental drug has demonstrated the ability to clear toxic tau tangles from the brain, a significant step…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Overcoming Cellular Differentiation Blocks
In a landmark advancement for hematologic oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy targeting acute…
Read More
Fat-Engorged Immune Cells Identified as Key Drivers of Rapid Disease Progression in Multiple Sclerosis Patients
A collaborative research effort led by Daan van der Vliet and a multidisciplinary team from the Netherlands Institute for Neuroscience,…
Read More
University of Florida Study Suggests Popular Joint Supplement Glucosamine May Accelerate Cognitive Decline in Alzheimer’s Patients
A groundbreaking study led by researchers at the University of Florida has uncovered a potential link between the use of…
Read More
Breakthrough Molecule OLE Offers New Hope for Restoring Brain Immune Function in Alzheimer Disease Patients
In a significant advancement for neurodegenerative research, a collaborative team of scientists from Spain and Switzerland has identified an experimental…
Read More
University of Arizona Study Reveals Human Heart Muscle Regeneration in Patients with Artificial Pumps Opening Potential Paths to Curing Heart Failure
A groundbreaking study co-led by a physician-scientist at the University of Arizona College of Medicine – Tucson’s Sarver Heart Center…
Read More
US FDA Grants Priority Review to Bristol Myers Squibb’s Camzyos for Adolescent Patients with Obstructive Hypertrophic Cardiomyopathy
The US Food and Drug Administration (FDA) has accepted Bristol Myers Squibb’s (BMS) supplemental new drug application (sNDA) for Camzyos…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Patients by Dismantling Differentiation Barriers
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read MoreYOU MAY HAVE MISSED
